Literature DB >> 22609366

Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder.

Melissa L Murphy1, Angela Carballedo, Andrew J Fagan, Derek Morris, Ciara Fahey, James Meaney, Thomas Frodl.   

Abstract

BACKGROUND: Polymorphisms in the brain-derived neurotrophic factor (BDNF) gene and its receptor neurotrophic tyrosine kinase receptor type 2 (NTRK2) have been implicated in mood disorders. The aim of this study was to examine whether the NTRK2 and BDNF polymorphisms impact brain white matter connections in major depressive disorder and whether they may also have an interactive effect with environmental stress in the form of early life adversity.
METHODS: The study group comprised 45 depressed patients and 45 age- and gender-matched control subjects. High angular resolution diffusion images were obtained and analyzed using tract-based spatial statistics. Analysis of a single nucleotide polymorphism in the BDNF (rs6265/Valine66Methionine) and NTRK2 (rs11140714) genes was performed.
RESULTS: An interactive effect was found between NTRK2 and depression diagnosis maximally affecting the cingulum. Depressed patients homozygous for the A allele of NTRK2 showed significantly reduced fractional anisotropy compared with depressed patients with at least one copy of the G allele or control subjects with either the A/A or G carrier genotypes in the left and right corona radiata, left uncinate fasciculus, left inferior fronto-occipital fasciculus, left cerebral peduncle, posterior thalamic radiation, and middle cerebral peduncle. Significantly smaller gray matter volume was seen in frontal lobe regions in patients homozygous for the A allele.
CONCLUSIONS: Polymorphisms in NTRK2 gene increase risk of architectural changes in several brain regions involved in emotional regulation.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609366     DOI: 10.1016/j.biopsych.2012.04.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  19 in total

Review 1.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.

Authors:  Mary L Phillips; Henry W Chase; Yvette I Sheline; Amit Etkin; Jorge R C Almeida; Thilo Deckersbach; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2015-02-01       Impact factor: 18.112

2.  Graph theoretical measures of the uncinate fasciculus subnetwork as predictors and correlates of treatment response in a transdiagnostic psychiatric cohort.

Authors:  Paul J Thomas; Srinivas Panchamukhi; Joshua Nathan; Jennifer Francis; Scott Langenecker; Stephanie Gorka; Alex Leow; Heide Klumpp; K Luan Phan; Olusola A Ajilore
Journal:  Psychiatry Res Neuroimaging       Date:  2020-03-05       Impact factor: 2.376

3.  Local gyrification index in patients with major depressive disorder and its association with tryptophan hydroxylase-2 (TPH2) polymorphism.

Authors:  Kyu-Man Han; Eunsoo Won; June Kang; Aram Kim; Ho-Kyoung Yoon; Hun Soo Chang; Kyu Ri Son; Min-Soo Lee; Woo-Suk Tae; Byung-Joo Ham
Journal:  Hum Brain Mapp       Date:  2016-11-03       Impact factor: 5.038

4.  A diffusion tensor imaging study of suicide attempters.

Authors:  Doreen M Olvet; Denis Peruzzo; Binod Thapa-Chhetry; M Elizabeth Sublette; Gregory M Sullivan; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  J Psychiatr Res       Date:  2014-01-16       Impact factor: 4.791

5.  Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder.

Authors:  Zuowei Wang; Jinbo Fan; Keming Gao; Zezhi Li; Zhenghui Yi; Lingxiao Wang; Jia Huang; Chengmei Yuan; Wu Hong; Shunying Yu; Yiru Fang
Journal:  J Mol Neurosci       Date:  2013-01-15       Impact factor: 3.444

Review 6.  Diagnostic and therapeutic utility of neuroimaging in depression: an overview.

Authors:  Toby Wise; Anthony J Cleare; Andrés Herane; Allan H Young; Danilo Arnone
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-19       Impact factor: 2.570

7.  Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.

Authors:  Kyoung-Sae Na; Eunsoo Won; June Kang; Hun Soo Chang; Ho-Kyoung Yoon; Woo Suk Tae; Yong-Ku Kim; Min-Soo Lee; Sook-Haeng Joe; Hyun Kim; Byung-Joo Ham
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

8.  Disorganization of white matter architecture in major depressive disorder: a meta-analysis of diffusion tensor imaging with tract-based spatial statistics.

Authors:  Guangxiang Chen; Xinyu Hu; Lei Li; Xiaoqi Huang; Su Lui; Weihong Kuang; Hua Ai; Feng Bi; Zhongwei Gu; Qiyong Gong
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

9.  Effects of repeated adolescent stress and serotonin transporter gene partial knockout in mice on behaviors and brain structures relevant to major depression.

Authors:  Simona Spinelli; Tanja Müller; Miriam Friedel; Hannes Sigrist; Klaus-Peter Lesch; Mark Henkelman; Markus Rudin; Erich Seifritz; Christopher R Pryce
Journal:  Front Behav Neurosci       Date:  2013-12-31       Impact factor: 3.558

Review 10.  The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition.

Authors:  Tadahiro Numakawa; Misty Richards; Shingo Nakajima; Naoki Adachi; Miyako Furuta; Haruki Odaka; Hiroshi Kunugi
Journal:  Front Psychiatry       Date:  2014-09-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.